Celltrion
068270.KS
#757
Rank
HK$211.10 B
Marketcap
HK$1,027
Share price
1.25%
Change (1 day)
5.03%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of June 2024 : HK$12.25 Billion

According to Celltrion 's latest financial reports the company's total debt is HK$12.25 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31HK$4.90 B0.65%
2021-12-31HK$4.87 B-11.72%
2020-12-31HK$5.52 B65.62%
2019-12-31HK$3.33 B-7.93%
2018-12-31HK$3.62 B-22.85%
2017-12-31HK$4.69 B7.54%
2016-12-31HK$4.36 B-16.77%
2015-12-31HK$5.24 B-12.35%
2014-12-31HK$5.98 B8.61%
2013-12-31HK$5.51 B23.24%
2012-12-31HK$4.47 B60.16%
2011-12-31HK$2.79 B47.08%
2010-12-31HK$1.89 B13.37%
2009-12-31HK$1.67 B16.08%
2008-12-31HK$1.44 B528.74%
2007-12-31HK$0.22 B